Literature DB >> 15184312

The best type of trial.

J A Chris Delaney.   

Abstract

Mesh：

Year:  2004        PMID： 15184312      PMCID： PMC419746          DOI： 10.1503/cmaj.1040320

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Why don't we initiate more large simple randomized controlled trials?

Authors:  James M Wright
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

2.  Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery.

Authors:  M A Hlatky; R M Califf; F E Harrell; K L Lee; D B Mark; D B Pryor
Journal:  J Am Coll Cardiol       Date:  1988-02       Impact factor: 24.094

Review 3.  Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies.

Authors:  E Garbe; S Suissa
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

4.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  4 in total
  1 in total

1.  Clinical trial budgets.

Authors:  J A Delaney; Andrei S P Brennan
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.